GW Pharmaceuticals SWOT Analysis, Competitors, STP & USP

Published by MBA Skool Team, Last Updated: April 12, 2020

SWOT analysis of GW Pharmaceuticals analyses the brand/company with its strengths, weaknesses, opportunities & threats. In GW Pharmaceuticals SWOT Analysis, the strengths and weaknesses are the internal factors whereas opportunities and threats are the external factors.

SWOT Analysis is a proven management framework which enables a brand like GW Pharmaceuticals to benchmark its business & performance as compared to the competitors and industry. GW Pharmaceuticals is one of the leading brands in the pharma and healthcare sector.

The table below lists the SWOT (Strengths, Weaknesses, Opportunities, Threats), top GW Pharmaceuticals competitors and includes GW Pharmaceuticals target market, segmentation, positioning & Unique Selling Proposition (USP).

GW Pharmaceuticals SWOT Analysis, Competitors, Segmentation, Target Market, Positioning, USP & Brand Analysis Table
GW Pharmaceuticals Brand Analysis
Parent Company

GW Pharmaceuticals




Pharma and Healthcare

Tagline/ Slogan



Its MS treatment product

GW Pharmaceuticals STP
GW Pharmaceuticals Segmentation


GW Pharmaceuticals Target Market

People suffering from multiple sclerosis, epilepsy and cancer

GW Pharmaceuticals Positioning

Focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform

GW Pharmaceuticals SWOT Analysis
GW Pharmaceuticals Strengths

Below are the Strengths in the SWOT Analysis of GW Pharmaceuticals:

1. GW Pharmaceuticals has the only cultivation license in the United Kingdom from the Home Office and theMHRA, to cultivate cannabis from seeds and clones to conduct scientific research concerning the medicinal uses of the plant
2. GW Pharmaceuticals concluded a partnership with Bayer for the distribution of Sativex in North America
3. GW is researching a large number of cannabinoids, each of which has different effects and applications

4.Collaboration with various educational institutes for R&D.

5. Strong expertise in the industry

GW Pharmaceuticals Weaknesses

Here are the weaknesses in the GW Pharmaceuticals SWOT Analysis:

1. Health issues due to side effects of cannabis
2.Human rights issues as cannabis is considered as a harmful drug
3.Legal issues in cultivating medical cannabis

4.Requires very high quality control in cultivating medical cannabis

GW Pharmaceuticals Opportunities

Following are the Opportunities in GW Pharmaceuticals SWOT Analysis:

1. Its cannabis-based product, Epidiolex, developed for experimental treatment of epilepsy, will undergo stage-two trials in the US in 2014
2. Tie ups with large hospitals can be a huge opportunity
3.Scope of entering into other segments of pharmaceuticals

GW Pharmaceuticals Threats

The threats in the SWOT Analysis of GW Pharmaceuticals are as mentioned:

1.It has only one major drug Sativex, contribute maximum to the revenue
2.Need for continuous innovation
3.Stringent government rules and quality control measures

GW Pharmaceuticals Competition

Below are the top 3 GW Pharmaceuticals competitors:

1.Shire UK
2.Teva UK Limited
3.Meda Pharmaceuticals UK


This article has been researched & authored by the Content & Research Team. It has been reviewed & published by the MBA Skool Team. The content on MBA Skool has been created for educational & academic purpose only.

Similar analysis has also been done for the competitors of the company belonging to the same category, sector or industry. Browse marketing analysis of more brands and companies similar to GW Pharmaceuticals. The BrandGuide section covers SWOT Analysis, Competitors, Segmentation, Target Market, Positioning & USP of more than 2800 brands from over 20 industry sectors.

Search & Explore : BrandGuide

The brand names and other brand information used in the BrandGuide section are properties of their respective companies. The companies are not associated with MBA Skool in any way.
Edit the Brand or Add a New One : Contribute to BrandGuide
Share this Page on:
Facebook ShareTweetShare on Linkedin